SK282768B6 - D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom - Google Patents

D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom Download PDF

Info

Publication number
SK282768B6
SK282768B6 SK1432-98A SK143298A SK282768B6 SK 282768 B6 SK282768 B6 SK 282768B6 SK 143298 A SK143298 A SK 143298A SK 282768 B6 SK282768 B6 SK 282768B6
Authority
SK
Slovakia
Prior art keywords
mannitol
crystals
examples
hydrochloride
surface area
Prior art date
Application number
SK1432-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK143298A3 (en
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK282768(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK143298A3 publication Critical patent/SK143298A3/sk
Publication of SK282768B6 publication Critical patent/SK282768B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Steroid Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SK1432-98A 1996-04-16 1997-04-14 D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom SK282768B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
PCT/JP1997/001286 WO1997038960A1 (en) 1996-04-16 1997-04-14 D-mannitol and its preparation

Publications (2)

Publication Number Publication Date
SK143298A3 SK143298A3 (en) 1999-04-13
SK282768B6 true SK282768B6 (sk) 2002-12-03

Family

ID=14109240

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1432-98A SK282768B6 (sk) 1996-04-16 1997-04-14 D-Manitol, spôsob jeho prípravy a kompozícia s jeho obsahom

Country Status (27)

Country Link
US (1) US6503918B2 (de)
EP (1) EP0902777B2 (de)
KR (1) KR20000005486A (de)
CN (1) CN1221398A (de)
AT (1) ATE202768T1 (de)
AU (1) AU718658B2 (de)
BG (1) BG63460B1 (de)
BR (1) BR9708672A (de)
CA (1) CA2251092A1 (de)
CU (1) CU22776A3 (de)
CZ (1) CZ333698A3 (de)
DE (1) DE69705516T3 (de)
DK (1) DK0902777T4 (de)
EA (1) EA000968B1 (de)
ES (1) ES2158540T5 (de)
GR (1) GR3036760T3 (de)
HU (1) HUP9902165A3 (de)
ID (1) ID16566A (de)
IL (1) IL126580A (de)
NO (2) NO311349B1 (de)
NZ (1) NZ332313A (de)
PL (1) PL329614A1 (de)
PT (1) PT902777E (de)
SK (1) SK282768B6 (de)
TR (1) TR199802079T2 (de)
TW (1) TW515787B (de)
WO (1) WO1997038960A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
RU2281757C2 (ru) * 2000-09-19 2006-08-20 Дайити Фармасьютикал Ко., Лтд. Фармацевтическая композиция
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
CN101404892B (zh) * 2002-05-14 2012-04-04 Fmc有限公司 微晶纤维素组合物
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
JP5053865B2 (ja) * 2005-12-28 2012-10-24 武田薬品工業株式会社 口腔内崩壊性固形製剤の製造法
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
EP2076249A2 (de) * 2006-10-27 2009-07-08 FMC Corporation Trockene granulationsbindemittel, produkte und ihre verwendung
BRPI0808889A2 (pt) * 2007-03-13 2014-11-11 Dainippon Sumitomo Pharma Co Comprimido desintegrante oral
CA2687813C (en) * 2007-05-22 2015-07-07 Ssci, Inc. Preparation of mannitol modification iii
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
CN103429229A (zh) 2010-12-17 2013-12-04 默克专利股份有限公司 可直接压片的δ-甘露糖醇的制备方法
CN103857739B (zh) 2011-10-05 2017-04-19 Fmc有限公司 共磨碎微晶纤维素和羧甲基纤维素的稳定剂组合物、制备方法和应用
JP6188030B2 (ja) 2011-10-05 2017-08-30 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 微結晶セルロースおよびカルボキシメチルセルロースの安定化剤組成物、該組成物の製造方法並びに食品製品
CN104010522A (zh) 2011-12-09 2014-08-27 Fmc有限公司 共磨碎稳定剂组合物
US10342247B2 (en) * 2014-07-21 2019-07-09 Roquette Freres Sugar compositions for tableting by direct compression
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
MX2022011215A (es) * 2020-03-31 2022-10-07 Eisai R&D Man Co Ltd Comprimido, medicamento, metodos para producirlos y kit.
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
DE69022861T2 (de) 1989-01-24 1996-04-04 Spi Polyols Inc Kryoschützende kristalline Sorbitolkügelchen.
DE69005679T2 (de) 1989-03-29 1994-06-23 Takeda Chemical Industries Ltd Zusammensetzung mit einer Verbindung der Vitamin B-Gruppe und ihre Herstellung.
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
EP0902777A1 (de) 1999-03-24
BR9708672A (pt) 1999-08-03
ID16566A (id) 1997-10-16
EP0902777B2 (de) 2004-06-16
BG63460B1 (bg) 2002-02-28
WO1997038960A1 (en) 1997-10-23
EA000968B1 (ru) 2000-08-28
NO20012249D0 (no) 2001-05-07
AU718658B2 (en) 2000-04-20
IL126580A0 (en) 1999-08-17
BG102818A (en) 1999-05-31
NO984803D0 (no) 1998-10-15
CZ333698A3 (cs) 1999-01-13
GR3036760T3 (en) 2001-12-31
CU22776A3 (es) 2002-07-24
EP0902777B1 (de) 2001-07-04
ES2158540T5 (es) 2004-11-16
PL329614A1 (en) 1999-03-29
HUP9902165A2 (hu) 1999-11-29
NO20012249L (no) 1998-12-16
DE69705516T2 (de) 2002-04-25
CN1221398A (zh) 1999-06-30
DK0902777T4 (da) 2004-10-11
KR20000005486A (ko) 2000-01-25
PT902777E (pt) 2001-11-30
CA2251092A1 (en) 1997-10-23
NO984803L (no) 1998-12-16
TW515787B (en) 2003-01-01
TR199802079T2 (xx) 1999-02-22
NZ332313A (en) 2000-02-28
US20020107420A1 (en) 2002-08-08
IL126580A (en) 2001-08-08
AU2522297A (en) 1997-11-07
DE69705516T3 (de) 2004-09-30
DK0902777T3 (da) 2001-09-24
NO311349B1 (no) 2001-11-19
HUP9902165A3 (en) 2001-01-29
DE69705516D1 (de) 2001-08-09
SK143298A3 (en) 1999-04-13
ATE202768T1 (de) 2001-07-15
US6503918B2 (en) 2003-01-07
ES2158540T3 (es) 2001-09-01
EA199800888A1 (ru) 1999-04-29

Similar Documents

Publication Publication Date Title
SK143298A3 (en) D-mannitol and its preparation
US6235947B1 (en) D-mannitol and its preparation
LV12731B (en) FORMULA FOR ORAL MEDICINAL PRODUCTS
US6635278B1 (en) Pharmaceutical formulations
AU2010297357A1 (en) (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
JP4773456B2 (ja) 生体利用率を向上させた経口用製剤
JP3126683B2 (ja) Ｄ−マンニトールおよびその製造法
CN117122570A (zh) 一种提高稳定性的美阿沙坦钾片及其制备方法
US20010001106A1 (en) D-mannitol and its preparation
US8846085B2 (en) Method for production of directly compressible ibuprofen formulations
JP2001114712A (ja) Ｄ−マンニトールおよびその製造法
WO2005020979A1 (en) A process for the preparation of pharmaceutical compositions of nateglinide
EP1142878B1 (de) Moexipril-Magnesium enthaltende Arzneimittel
CN1193906A (zh) 治疗用的泡腾组合物
HK1020567A (en) D-mannitol and its preparation
JP3232687B2 (ja) イミダプリル含有製剤
US7691410B2 (en) Use of dicalcium phosphate anhydride powder
KR101811030B1 (ko) 테노포비어 디소프록실 인산염과, 비금속염 붕해제 및 비금속염 활택제를 포함하는 약학 조성물
CN118804750A (zh) 含有特力利汀的颗粒和包含该颗粒的制剂
CA2306633A1 (en) Effervescent base
EA040745B1 (ru) Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения
HK1074009A (en) Flash-melt oral dosage formulation
HK1038192A (en) Pharmaceutical preparation containing levothyroxine sodium